BioSpace News Archive

Total revenue for the third quarter increased 165% year over year to $489,000, compared to $184,000 for the third quarter of 2016.

Symphony Clinical Research received national re-certification as a Women’s Business Enterprise by the Women’s Business Development Center-Chicago, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC).

Cellectis is currently working with the investigators and clinical sites to obtain IRB’s approval on the revised protocols and resume patient enrollment.

Sectra is launching vendor-neutral access to machine learning in its enterprise imaging platform.

Revenue for the three months ended September 30, 2017 increased 126% to $17.2 million compared to $7.6 million in the year-ago third quarter.

QIAGEN N.V. announced results of operations for the third quarter and first nine months of 2017, delivering on goals for improvements in adjusted net sales and adjusted earnings.

The Company is posting this press release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website.

Third quarter record quarterly net sales of $1.20B, up 5.2% year-over-year, and up 2.2% on an organic basis.

Schrodinger and ShanghaiTech University will embark on joint research projects to solve challenging scientific problems in molecular recognition of the human body that can lead to co-discoveries.

Based on this double-blinded, placebo-controlled, multi-center study, data are presented from 93 subjects with bilateral knee OA who received 4 weekly doses of TPX-100 by intra-articular administration in one knee and identical placebo injections in the other, with at least one follow-up evaluation at 6 and 12 months.